Evitria AG specializes in the production of recombinant antibodies using CHO (Chinese Hamster Ovary) cells, a widely utilized system in biopharmaceutical manufacturing. The company has honed its expertise in this area since its establishment in 2010, focusing exclusively on recombinant antibody expression. This specialization allows Evitria to offer rapid turnaround times, with projects typically initiated within 24 hours of approval and completed in as little as four weeks. Their production process emphasizes high quality, achieving very low levels of endotoxin (<1 EU/mg), which is crucial for therapeutic applications. The range of antibodies produced includes afucosylated, bispecific, and Fc-silenced antibodies, among others, tailored for various applications in diagnostics and therapeutics.

The recombinant antibody production process at Evitria involves several key steps, including the identification of target antigens, generation of antibody libraries, and optimization of antibody properties through engineering techniques. The company employs mammalian cell expression systems, particularly CHO cells, due to their ability to perform necessary post-translational modifications that enhance the functionality and stability of the antibodies. This method allows for the production of homogeneous antibodies that can be specifically designed to target particular epitopes, making them suitable for a wide range of clinical applications. Evitria's commitment to quality and efficiency has positioned it as a reliable partner in the biotechnology sector, with over 120,000 production runs supporting clients globally.

Switzerland

​evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies). 

With a track record of more than 120,000 successful antibody production runs for our clients, we can offer fast and reliable project execution at high quality standards (all production facilities in Switzerland).

You can benefit from our expertise and unique focus when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects. 

evitria

Company Details